The smart therapeutic devices market size was valued at USD 76.41 billion in 2024 and is expected to reach USD 204.02 billion by 2032, growing at a CAGR of 13.09% over the forecast period of 2025-2032.
Rapid growth in the global smart therapeutic devices market is attributed to the rising prevalence of chronic disease, increasing awareness about health, and real-time, personalized treatment. The ability to deliver targeted treatment at home has been revolutionized by the advent of smart neurotechnological devices that embed IoT, AI, and wireless technology with current therapeutic devices to maximize efficacy, adherence, and device-free treatments. In addition, the smart therapeutic devices market growth of smart therapeutic devices is attributed to an increase in favorable home healthcare reimbursement policies and a rise in the adoption of remote monitoring.
The U.S. smart therapeutic devices market size was valued at USD 24.41 billion in 2024 and is expected to reach USD 63.66 billion by 2032, growing at a CAGR of 12.76% over the forecast period of 2025-2032.
With a well-established healthcare infrastructure, a developed R&D ecosystem, and the presence of a number of leading med-tech players across the country, the U.S. dominated the smart therapeutic device market in North America. Coupled with great investment in healthcare, pro-innovation regulatory policies, and widespread adoption of connected therapeutic technologies through hospitals and home-care settings, this leadership is also augmented by continued investment.
The FDA (Dec 2024) announced new guidelines to accelerate the approval of AI-enabled medical devices by permitting manufacturers to update approved products without the need to submit full regulatory dossiers.
Drivers:
Increasing Prevalence of Chronic Diseases is Driving the Market Growth
The global prevalence of chronic diseases, including cardiovascular conditions, diabetes, respiratory diseases, and neurological disorders, is on the rise, leading to increased demand for safe, effective, and efficient management options for prolonged periods.
Non-communicable diseases (NCDs), based on the World Health Organization (WHO) best estimates, contribute to around 74% of all global deaths, with 17.9 million people dying from cardiovascular diseases.
For instance, in the case of diabetes, the numbers are alarming, as the International Diabetes Federation (IDF) estimated that by 2024, more than 540 million people globally will be living with diabetes, and the numbers are staggering in the upcoming years.
Continuous monitoring and disease-specific therapy make smart therapeutic devices, such as insulin pumps, smart drug delivery systems, and neurostimulation devices, essential for optimal patient management. By individualizing therapy, automating dosing, and allowing for real-time monitoring of dosing and response, they may facilitate improvements in disease control while also lessening the burden on healthcare systems.
Advancements in Digital Health Technologies are Propelling the Market Growth
Therapeutic care is undergoing important changes due to technological innovation. Smart and connected therapeutic devices, empowered by technologies such as Internet of Things (IoT), Artificial Intelligence (AI), Bluetooth, and cloud computing, support real-time data tracking and remote access to devices. Smart drug delivery systems, for instance, can be programmed to autonomously adjust the quantity of medication released into the bloodstream using real-time physiological feedback, and wearable neurostimulation devices can be programmed with a mobile app to deliver user-specific therapy.
Remote patient monitoring (RPM) has seen increased uptake globally, and the American Medical Association conducted a survey in 2023 that found that over 70% of physicians across the U.S. were using some form of RPM to care for patients.
Moreover, clinical trials have found that sensor-equipped smart inhalers can enhance medication adherence by as much as 58%. Adjuncts to traditional inhalers. Another motivation is the increasing use of telehealth, together with various government policies encouraging the digital health infrastructure, particularly in the older demographics and marginalized areas.
The FDA approved 252 AI algorithms for digital healthcare, and the number of AI/ML-enabled digital health devices rose to approximately 801 in number by mid-2024.
Restraints
High Cost and Limited Accessibility of Advanced Devices, Particularly in Low- and Middle-Income Regions, are Restraining the Smart Therapeutic Devices Market Trends
A lot of smart therapeutic devices, from insulin pumps and neurostimulation systems to smart drug delivery platforms, incorporate or are embedded with state-of-the-art technologies, such as IoT, artificial intelligence (AI), and wireless communications. These advancements help with functionality and optimal usage, but they impose a substantially higher price tag on patients and the healthcare industry. In poorly developed healthcare infrastructure or where reimbursement frameworks are weak, affordability will be a significant impediment to adoption.
Smart insulin pumps are a good example, with annual costs running into thousands of dollars, and continuous glucose monitors (CGMs) may incur additional continuous costs, such as those related to sensors and software upgrades. Out-of-pocket expenses still represent a major barrier to adherence to chronic disease management in developed countries, and more so in populations that lack insurance or are underinsured, according to the U.S. CDC. Moreover, the absence of trained professionals to install, calibrate, and maintain these devices, coupled with other aspects, such as data privacy, cybersecurity concerns, and device interoperability, may impede widespread market penetration, especially in rural and resource-constrained settings.
By Device Types
The smart therapeutic devices market is led by the smart drug delivery systems segment with a 49.28% market share in 2024, attributed to the rising applications of smart drug delivery systems being integrated into the chronic disease treatment regimens. These systems improve the accuracy of delivering medicines, which subsequently improves patient compliance with treatments and outcomes. This enables real-time tracking of dosage, timing, and physiological response, which can be extremely useful in the clinic and in at-home treatment. This shift toward personalization in drug administration has also contributed to an increase in their adoption rates, while the larger shift towards connected drug delivery platforms has ensured the long-term continued adoption of these devices.
The neurostimulation devices segment is anticipated to register the fastest growth throughout the forecast period. The rapid growth is mainly driven by the increasing number of neurological disorders, including Parkinson's disease, epilepsy, chronic pain, and an increasing preference toward non-pharmacological treatment options. Technological progress is progressing miniaturization, wireless communication, and the consequent linearity of performance-to-comfort payloads. Furthermore, growing research budgets and increasing indications and approvals for new applications are driving fast adoption in both developed and emerging markets.
By Distribution Channel
The pharmacies segment dominated the smart therapeutic devices market share with 38.60% in 2024, owing to the availability of these devices on a large scale and the high level of consumer trust in pharmacies as distributors and effective distribution channels. Pharmacies are still an important place where patients buy prescribed smart therapeutic devices, such as insulin pumps, smart inhalers, and drug delivery systems. This gives them a critical edge as the go-to distribution channel as they can provide in-person consultation, support with device use, and integration with insurance and reimbursement services. The dominance is further fueled by the partner developer to the device manufacturers, which are among the most prominent chains of supermarkets found in most countries.
The online channel segment is predicted to have the fastest growth over the forecast years, owing to rising convenience, home delivery, and a wider array of products and services preferred by the consumer. Booming e-commerce platforms, telehealth services, and direct-to-consumer models allow patients to acquire smart therapeutic devices remotely, particularly in countries where digital infrastructures have been growing. In addition to this, the COVID-19 pandemic fast-tracked the adoption of digital change in healthcare, and online platforms are increasingly accepted for medical device purchases. Better user interfaces, safe payment systems, and subscription models are also making online channels more attractive for consumers and providers alike.
By End-Use
The hospitals segment accounted for the largest share of the 2024 market with a 63.18% market share in the smart therapeutic devices market, due to the high number of such advanced treatment procedures and availability of specialists, and integration of advanced therapeutic technologies within hospitals. Hospitals are typically the first point at which chronic and acute conditions are diagnosed and managed, thereby making them early adopters of smart devices, including neurostimulation systems, drug delivery tools, and connected ventilators. Then there are the generous financial resources that hospitals can leverage, their established processes and procedures for getting these types of devices, and their long-standing infrastructure to manage the deployment and monitoring of these types of devices, all driving the hospital to the center of the market even further.
The home care segment is expected to be the fastest-growing end-use category during the forecast period due to the global movement towards decentralized healthcare and patient-centered treatment models. Demand for these smart therapeutic devices is being spurred due to growing preference for managing chronic conditions, diabetic patients, such as at home, including real-time monitoring and automatic dosing, and feedback of information collected to providers. Innovation of user-friendly, portable, app-attached solutions, together with the rising cost of care and an older population, is motivating patients and patient care to seek home-based solutions, which minimize hospitalization and improve the quality of life.
North America dominated the smart therapeutic devices market with a 43.10% market share in 2024, due to the sophisticated healthcare infrastructure it offers, a high presence of prominent medical technology companies, and the rising awareness of chronic diseases being managed from connected solutions across North America. The region offers the advantages of early uptake of digital health technologies, strong investment in research and development, and supportive reimbursement policies for smart devices, such as insulin pumps, neurostimulators, and wearables. In addition, in the U.S. and Canada, the rising burden of lifestyle-related disorders, including diabetes and cardiovascular disease, will continue to bolster demand for these technologies.
The smart therapeutic devices market is experiencing the fastest growth in Asia Pacific with a 13.71% CAGR over the forecast period due to the wellness field getting more investment as a better healthcare infrastructure is built on the increasing population and a higher incidence of chronic diseases. Investments in digital health, telemedicine, and mobile health technologies have been flowing into countries such as China, India, and Japan. In addition, the rising penetration of the internet and smartphones, coupled with government efforts to boost remote care access, is expected to propel demand for smart therapeutic devices. Moreover, the expansion of the region's middle class and increased awareness about healthcare are boosting the demand for low-cost and interconnected health solutions.
Europe’s enormous public investment in digital health is likely to contribute to considerable expansion of the smart therapeutic devices market, further bolstered by other healthcare modernization initiatives, such as the EU’s Digital Health and Care Strategy. More of the region's existing healthcare systems and reimbursement programs are beginning to accommodate remote monitoring technologies, such as continuous glucose monitors, smart inhalers, and neurostimulation devices. Moreover, stringent regulations and extensive digital infrastructure promote the integration of connected therapies within chronic disease management protocols, facilitating innovation and adoption across the European landscape.
The global smart therapeutic devices market is growing at a moderate pace in Latin America due to the rising awareness regarding chronic disease management and increasing inclination toward remote healthcare solutions. Various smart devices, such as insulin pumps and remote monitoring tools, are being incorporated into healthcare delivery in countries across the region, particularly in urban settings. The proliferation of supportive public health programs and increasing access to mobile health technologies are also driving the steady expansion of the market.
The MEA region is growing moderately, owing to all the ongoing investments in healthcare infrastructure and digital transformation. Chronic diseases, such as diabetes and cardiovascular disease, are on the rise, which is supporting growth in smart therapeutic devices to be used in clinical settings and also at home, with more and more healthcare systems focusing on patient-centered home care. Since the combination of governmental drives scaling telehealth and remote care, followed by internet penetration increments, the region is slowly embracing advanced therapeutic technologies.
Smart therapeutic devices companies are Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., Dexcom, Inc., Fitbit (Google), Johnson & Johnson, ResMed Inc., Boston Scientific, Omada Health, Pear Therapeutics, and other players.
June 2025 –Royal Philips, a global leader in health technology, released the CE marking of its SmartCT image reconstruction solution in June 2025. The solution is intended to support quicker and better-informed decision-making in the treatment of stroke and other neurovascular conditions. SmartCT is now available in Europe after previously being available in Japan and Canada. The innovation will be presented at LINNC Paris 2025 (June 2–4), a leading international congress in interventional neuroradiology.
In January 2024, Abbott launched a new chapter in its FreeStyle Libre system with the release of its newest continuous glucose monitoring (CGM) sensor. The product brings added value specifically to the U.S. insulin pump users, solidifying Abbott's leadership role in the diabetes care market.
August 2024, Medtronic plc announced FDA clearance for its Simplera continuous glucose monitor (CGM), the company's first all-in-one, disposable CGM. The new device, which is half the size of its predecessors, has a more discreet profile and does away with overtape, making both insertion and wear easier for users.
| Report Attributes | Details |
|---|---|
| Market Size in 2024 | USD 77.12 Billion |
| Market Size by 2032 | USD 204.02 Billion |
| CAGR | CAGR of 13.09% From 2025 to 2032 |
| Base Year | 2024 |
| Forecast Period | 2025-2032 |
| Historical Data | 2021-2023 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Device Type (Portable Oxygen Concentrators & Ventilators, Insulin Pumps, Hearing Aids, Neurostimulation Devices, Smart Inhalers, Smart Drug Delivery Systems) • By Distribution Channel (Pharmacies, Online Channel, Direct-to-Consumer (DTC), Others [Hypermarkets, Specialty Retailers]) • By End Use (Hospitals, Clinics, Home Care, Others [Sports, Fitness Centers, Assisted Living]) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Poland, Turkey, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., Dexcom, Inc., Fitbit (Google), Johnson & Johnson, ResMed Inc., Boston Scientific, Omada Health, Pear Therapeutics, and other players. |
Ans: The Smart Therapeutic Devices Market is expected to grow at a CAGR of 13.09% from 2025 to 2032.
Ans: The Smart Therapeutic Devices Market was USD 76.41 billion in 2024 and is expected to reach USD 204.02 billion by 2032.
Ans: Rising prevalence of chronic diseases is driving the market growth.
Ans: The “Smart Drug Delivery Systems” segment dominated the Smart Therapeutic Devices Market.
Ans: North America dominated the Smart Therapeutic Devices Market in 2024.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Adoption Rates and User Base (2024)
5.2 Condition-Wise Usage Trends (2024)
5.3 Technology Penetration and Connectivity Trends (2024)
5.4 Reimbursement and Insurance Coverage Trends (2024)
5.5 Patient Adherence and Outcomes Data (2024)
5.6 Healthcare Spending on Smart Therapeutics, by Region (2024)
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new Product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Smart Therapeutic Devices Market Segmentation By Device Types
7.1 Chapter Overview
7.2 Portable Oxygen Concentrators & Ventilators
7.2.1 Portable Oxygen Concentrators & Ventilators Market Trends Analysis (2021-2032)
7.2.2 Portable Oxygen Concentrators & Ventilators Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Insulin Pumps
7.3.1 Insulin Pumps Market Trends Analysis (2021-2032)
7.3.2 Insulin Pumps Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Hearing Aids
7.4.1 Hearing Aids Market Trends Analysis (2021-2032)
7.4.2 Hearing Aids Market Size Estimates and Forecasts to 2032 (USD Billion)
7.5 Neurostimulation Devices
7.5.1 Neurostimulation Devices Market Trends Analysis (2021-2032)
7.5.2 Neurostimulation Devices Market Size Estimates and Forecasts to 2032 (USD Billion)
7.6 Smart Inhalers
7.6.1 Smart Inhalers Market Trends Analysis (2021-2032)
7.6.2 Smart Inhalers Market Size Estimates and Forecasts to 2032 (USD Billion)
7.7 Smart Drug Delivery Systems
7.7.1 Smart Drug Delivery Systems Market Trends Analysis (2021-2032)
7.7.2 Smart Drug Delivery Systems Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Smart Therapeutic Devices Market Segmentation By Distribution Channel
8.1 Chapter Overview
8.2 Pharmacies
8.2.1 Pharmacies Market Trend Analysis (2021-2032)
8.2.2 Pharmacies Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Online Channel
8.3.1 Online Channel Market Trends Analysis (2021-2032)
8.3.2 Online Channel Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Direct-to-Consumer (DTC)
8.4.1 Direct-to-Consumer (DTC) Market Trends Analysis (2021-2032)
8.4.2 Direct-to-Consumer (DTC) Market Size Estimates and Forecasts to 2032 (USD Billion)
8.5 Others (Hypermarkets, Specialty Retailers)
8.5.1 Others (Hypermarkets, Specialty Retailers) Market Trends Analysis (2021-2032)
8.5.2 Others (Hypermarkets, Specialty Retailers) Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Smart Therapeutic Devices Market Segmentation By End User
9.1 Chapter Overview
9.2 Hospitals
9.2.1 Hospitals Market Trends Analysis (2021-2032)
9.2.2 Hospitals Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 Clinics
9.3.1 Clinics Market Trends Analysis (2021-2032)
9.3.2 Clinics Market Size Estimates and Forecasts to 2032 (USD Billion)
9.4 Home Care
9.4.1 Home Care Market Trends Analysis (2021-2032)
9.4.2 Home Care Market Size Estimates and Forecasts to 2032 (USD Billion)
9.5 Others (Sports, Fitness Centers, Assisted Living)
9.5.1 Others (Sports, Fitness Centers, Assisted Living) Market Trends Analysis (2021-2032)
9.5.2 Others (Sports, Fitness Centers, Assisted Living) Market Size Estimates and Forecasts to 2032 (USD Billion)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America Smart Therapeutic Devices Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.2.3 North America Smart Therapeutic Devices Market Estimates and Forecasts, By Device Types (2021-2032) (USD Billion)
10.2.4 North America Smart Therapeutic Devices Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.2.5 North America Smart Therapeutic Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.2.6 USA
10.2.6.1 USA Smart Therapeutic Devices Market Estimates and Forecasts, By Device Types (2021-2032) (USD Billion)
10.2.6.2 USA Smart Therapeutic Devices Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.2.6.3 USA Smart Therapeutic Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.2.7 Canada
10.2.7.1 Canada Smart Therapeutic Devices Market Estimates and Forecasts, By Device Types (2021-2032) (USD Billion)
10.2.7.2 Canada Smart Therapeutic Devices Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.2.7.3 Canada Smart Therapeutic Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.2.8 Mexico
10.2.8.1 Mexico Smart Therapeutic Devices Market Estimates and Forecasts, By Device Types (2021-2032) (USD Billion)
10.2.8.2 Mexico Smart Therapeutic Devices Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.2.8.3 Mexico Smart Therapeutic Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.3 Europe
10.3.1 Trends Analysis
10.3.2 Europe Smart Therapeutic Devices Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.3.3 Europe Smart Therapeutic Devices Market Estimates and Forecasts, By Device Types (2021-2032) (USD Billion)
10.3.4 Europe Smart Therapeutic Devices Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.3.5 Europe Smart Therapeutic Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.3.6 Germany
10.3.1.6.1 Germany Smart Therapeutic Devices Market Estimates and Forecasts, By Device Types (2021-2032) (USD Billion)
10.3.1.6.2 Germany Smart Therapeutic Devices Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.3.1.6.3 Germany Smart Therapeutic Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.3.7 France
10.3.7.1 France Smart Therapeutic Devices Market Estimates and Forecasts, By Device Types (2021-2032) (USD Billion)
10.3.7.2 France Smart Therapeutic Devices Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.3.7.3 France Smart Therapeutic Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.3.8 UK
10.3.8.1 UK Smart Therapeutic Devices Market Estimates and Forecasts, By Device Types (2021-2032) (USD Billion)
10.3.8.2 UK Smart Therapeutic Devices Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.3.8.3 UK Smart Therapeutic Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.3.9 Italy
10.3.9.1 Italy Smart Therapeutic Devices Market Estimates and Forecasts, By Device Types (2021-2032) (USD Billion)
10.3.9.2 Italy Smart Therapeutic Devices Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.3.9.3 Italy Smart Therapeutic Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.3.10 Spain
10.3.10.1 Spain Smart Therapeutic Devices Market Estimates and Forecasts, By Device Types (2021-2032) (USD Billion)
10.3.10.2 Spain Smart Therapeutic Devices Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.3.10.3 Spain Smart Therapeutic Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.3.12 Poland
10.3.12.1 Poland Smart Therapeutic Devices Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.3.12.1 Poland Smart Therapeutic Devices Market Estimates and Forecasts, By Device Types (2021-2032) (USD Billion)
10.3.12.3 Poland Smart Therapeutic Devices Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.3.12.3 Poland Smart Therapeutic Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.3.13 Turkey
10.3.13.1 Turkey Smart Therapeutic Devices Market Estimates and Forecasts, By Device Types (2021-2032) (USD Billion)
10.3.13.2 Turkey Smart Therapeutic Devices Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.3.13.3 Turkey Smart Therapeutic Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.3.14 Rest of Europe
10.3.14.1 Rest of Europe Smart Therapeutic Devices Market Estimates and Forecasts, By Device Types (2021-2032) (USD Billion)
10.3.14.2 Rest of Europe Smart Therapeutic Devices Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.3.14.3 Rest of Europe Smart Therapeutic Devices Market Estimates and Forecasts, By End User(2021-2032) (USD Billion)
10.4 Asia-Pacific
10.4.1 Trends Analysis
10.4.2 Asia-Pacific Smart Therapeutic Devices Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.4.3 Asia-Pacific Smart Therapeutic Devices Market Estimates and Forecasts, By Device Types (2021-2032) (USD Billion)
10.4.4 Asia-Pacific Smart Therapeutic Devices Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.4.5 Asia-Pacific Smart Therapeutic Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.4.6 China
10.4.6.1 China Smart Therapeutic Devices Market Estimates and Forecasts, By Device Types (2021-2032) (USD Billion)
10.4.6.2 China Smart Therapeutic Devices Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.4.6.3 China Smart Therapeutic Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.4.7 India
10.4.7.1 India Smart Therapeutic Devices Market Estimates and Forecasts, By Device Types (2021-2032) (USD Billion)
10.4.7.2 India Smart Therapeutic Devices Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.4.7.3 India Smart Therapeutic Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.4.8 Japan
10.4.8.1 Japan Smart Therapeutic Devices Market Estimates and Forecasts, By Device Types (2021-2032) (USD Billion)
10.4.8.2 Japan Smart Therapeutic Devices Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.4.8.3 Japan Smart Therapeutic Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.4.9 South Korea
10.4.9.1 South Korea Smart Therapeutic Devices Market Estimates and Forecasts, By Device Types (2021-2032) (USD Billion)
10.4.9.2 South Korea Smart Therapeutic Devices Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.4.9.3 South Korea Smart Therapeutic Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.4.10 Singapore
10.4.10.1 Singapore Smart Therapeutic Devices Market Estimates and Forecasts, By Device Types (2021-2032) (USD Billion)
10.4.10.2 Singapore Smart Therapeutic Devices Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.4.10.3 Singapore Smart Therapeutic Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.4.11 Australia
10.4.11.1 Australia Smart Therapeutic Devices Market Estimates and Forecasts, By Device Types (2021-2032) (USD Billion)
10.4.11.2 Australia Smart Therapeutic Devices Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.4.11.3 Australia Smart Therapeutic Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.4.12 Rest of Asia-Pacific
10.4.12.1 Rest of Asia-Pacific Smart Therapeutic Devices Market Estimates and Forecasts, By Device Types (2021-2032) (USD Billion)
10.4.12.2 Rest of Asia-Pacific Smart Therapeutic Devices Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.4.12.3 Rest of Asia-Pacific Smart Therapeutic Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.5 Middle East and Africa
10.5.1 Trends Analysis
10.5.2 Middle East and Africa East Smart Therapeutic Devices Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.5.3 Middle East and Africa Smart Therapeutic Devices Market Estimates and Forecasts, By Device Types (2021-2032) (USD Billion)
10.5.4 Middle East and Africa Smart Therapeutic Devices Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.5.5 Middle East and Africa Smart Therapeutic Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.5.6 UAE
10.5.6.1 UAE Smart Therapeutic Devices Market Estimates and Forecasts, By Device Types (2021-2032) (USD Billion)
10.5.6.2 UAE Smart Therapeutic Devices Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.5.6.3 UAE Smart Therapeutic Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.5.7 Saudi Arabia
10.5.7.1 Saudi Arabia Smart Therapeutic Devices Market Estimates and Forecasts, By Device Types (2021-2032) (USD Billion)
10.5.7.2 Saudi Arabia Smart Therapeutic Devices Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.5.7.3 Saudi Arabia Smart Therapeutic Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.5.8 Qatar
10.5.8.1 Qatar Smart Therapeutic Devices Market Estimates and Forecasts, By Device Types (2021-2032) (USD Billion)
10.5.8.2 Qatar Smart Therapeutic Devices Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.5.8.3 Qatar Smart Therapeutic Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.5.9 South Africa
10.5.9 1 South Africa Smart Therapeutic Devices Market Estimates and Forecasts, By Device Types (2021-2032) (USD Billion)
10.5.9 2 South Africa Smart Therapeutic Devices Market Estimates and Forecasts By Distribution Channel (2021-2032) (USD Billion)
10.5.9 3 South Africa Smart Therapeutic Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.5.10 Rest of Middle East & Africa
10.5.10.1 Rest of Middle East & Africa Smart Therapeutic Devices Market Estimates and Forecasts, By Device Types (2021-2032) (USD Billion)
10.5.10.2 Rest of Middle East & Africa Smart Therapeutic Devices Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.5.10.3 Rest of Middle East & Africa Smart Therapeutic Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America Smart Therapeutic Devices Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.6.3 Latin America Smart Therapeutic Devices Market Estimates and Forecasts, By Device Types (2021-2032) (USD Billion)
10.6.4 Latin America Smart Therapeutic Devices Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.6.5 Latin America Smart Therapeutic Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.6.6 Brazil
10.6.6.1 Brazil Smart Therapeutic Devices Market Estimates and Forecasts, By Device Types (2021-2032) (USD Billion)
10.6.6.2 Brazil Smart Therapeutic Devices Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.6.6.3 Brazil Smart Therapeutic Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.6.7 Argentina
10.6.7.1 Argentina Smart Therapeutic Devices Market Estimates and Forecasts, By Device Types (2021-2032) (USD Billion)
10.6.7.2 Argentina Smart Therapeutic Devices Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.6.7.3 Argentina Smart Therapeutic Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.6.8 Rest of Latin America
10.6.8.1 Rest of Latin America Smart Therapeutic Devices Market Estimates and Forecasts, By Device Types (2021-2032) (USD Billion)
10.6.8.2 Rest of Latin America Smart Therapeutic Devices Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.6.8.3 Rest of Latin America Smart Therapeutic Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
12. Company Profiles
12.1 Abbott Laboratories
12.1.1 Company Overview
12.1.2 Financial
12.1.3 Products/ Services Offered
12.1.4 SWOT Analysis
12.2 Medtronic plc.
12.2.1 Company Overview
12.2.2 Financial
12.2.3 Products/ Services Offered
12.2.4 SWOT Analysis
12.3 Koninklijke Philips N.V.,
12.3.1 Company Overview
12.3.2 Financial
12.3.3 Products/ Services Offered
12.3.4 SWOT Analysis
12.4 Dexcom, Inc.
12.4.1 Company Overview
12.4.2 Financial
12.4.3 Products/ Services Offered
12.4.4 SWOT Analysis
12.5 Fitbit (Google)
12.5.1 Company Overview
12.5.2 Financial
12.5.3 Products/ Services Offered
12.5.4 SWOT Analysis
12.6 Johnson & Johnson
12.6.1 Company Overview
12.6.2 Financial
12.6.3 Products/ Services Offered
12.6.4 SWOT Analysis
12.7 ResMed Inc.
12.7.1 Company Overview
12.7.2 Financial
12.7.3 Products/ Services Offered
12.7.4 SWOT Analysis
12.8 Boston Scientific
12.8.1 Company Overview
12.8.2 Financial
12.8.3 Products/ Services Offered
12.8.4 SWOT Analysis
12.9 Omada Health
12.9.1 Company Overview
12.9.2 Financial
12.9.3 Products/ Services Offered
12.9.4 SWOT Analysis
12.10 Pear Therapeutics
12.10.1 Company Overview
12.10.2 Financial
12.10.3 Products/ Services Offered
12.10.4 SWOT Analysis
12. Use Cases and Best Practices
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segments:
By Device Types
By Distribution Channel
By End Use
Request for Segment Customization as per your Business Requirement: https://www.snsinsider.com/sample-request/7614
Regional Coverage:
North America
Europe
Asia Pacific
Middle East & Africa
Latin America
Request for Country Level Research Report: https://www.snsinsider.com/sample-request/7614
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report: